Skip to main content
logo
AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
10.97
+0.61 (5.89%)
At close: Aug 13, 2026, 4:00 PM EDT
10.96
-0.01 (-0.09%)
After-hours: Aug 13, 2026, 7:59 PM EDT

AbCellera Biologics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
66.1775.1328.8338.03485.42375.2
Revenue Growth
101.28%160.56%-24.17%-92.17%29.38%60.92%
Gross Profit
66.1775.1328.8338.03485.42375.2
Operating Income
-225.16-217.1-314.77-237.21216.51204.41
Net Income
-164.66-146.41-162.86-146.4158.52153.46
Earnings Per Share
-0.54-0.49-0.55-0.510.500.48
EPS Growth
----4.17%6.67%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Research Fees
28.5327.2126.2835.5640.819.08
Milestone Payments
-11.51.50.98
Licensing and Royalty
36.6546.921.050.970.720.78
Revenue (Total)
66.1775.1328.8338.03485.42375.2

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
540.1533.83625.61760.59886.49722.98
Total Debt
129.95137.460.7471.2276.6836.41
Net Cash (Debt)
410.16396.42564.87689.36809.81686.56
Net Cash Growth
-1.38%-29.82%-18.06%-14.87%17.95%16.29%
Net Cash Per Share
1.361.331.922.382.572.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-94.94-131.3-108.56-43.88277.36244.58
Capital Expenditures
-24.73-42.77-78.4-76.95-70.66-58.45
Free Cash Flow
-119.67-174.07-186.95-120.82206.7186.13
Free Cash Flow Growth
----11.05%1329.91%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-340.25%-288.98%-1091.69%-623.82%44.60%54.48%
Pretax Margin
-297.36%-236.39%-695.02%-457.67%49.26%58.41%
Profit Margin
-248.83%-194.88%-564.83%-385.00%32.66%40.90%
FCF Margin
-180.85%-231.69%-648.40%-317.75%42.58%49.61%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----20.2629.79
Forward PE
-60.1560.1560.1560.1551.81
P/FCF Ratio
----14.0621.76
PS Ratio
50.8313.6830.0543.675.9910.80